Columbus, OH, United States of America

Christopher C Coss

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2022-2024

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Christopher C Coss in Cancer Treatment

Introduction

Christopher C Coss is an accomplished inventor based in Columbus, OH, known for his significant contributions to the field of cancer treatment. With a total of two patents to his name, Coss has focused his research on methods and compositions aimed at alleviating cancer cachexia, a condition that severely impacts patients suffering from cancer.

Latest Patents

Coss's latest patents include innovative methods and compositions for the treatment of cancer cachexia. One of the key aspects of his work involves a pharmaceutical composition that combines a class I/IIB HDAC inhibitor with an androgen. The method of treatment he proposes includes administering this combination to patients diagnosed with cancer cachexia. Notably, the class I/IIB HDAC inhibitor he references is a compound known as AR-42, which plays a crucial role in his treatment approach.

Career Highlights

Coss is affiliated with the Ohio State Innovation Foundation, where he continues to advance his research and development efforts. His work is pivotal in addressing the challenges faced by cancer patients, particularly those suffering from cachexia, which can significantly affect their quality of life.

Collaborations

Coss collaborates with esteemed colleagues such as Ching-Shih Chen and Samuel K Kulp, who contribute to the research and development of innovative solutions in cancer treatment.

Conclusion

Christopher C Coss's work exemplifies the importance of innovation in the medical field, particularly in the treatment of cancer cachexia. His patents and ongoing research hold promise for improving the lives of many patients facing this challenging condition.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…